In the second quarter of the fiscal year ending March 2027, all three business segments recorded revenue growth. Revenue was 14,284 million yen, operating income 2,150 million yen, ordinary income 2,185 million yen, and interim net income 1,577 million yen. For the second half, a substantial revenue increase is expected from the particle measurement instruments segment, while hearing aids and medical testing instruments are expected to see continued weak replacement demand. Dividend is expected at approximately 90 yen for the full year (up from 85 yen). Total assets were 43,161 million yen, and the equity ratio was 83.5%.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6823","jir_company_name":"Rion Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-29","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/6823-20261029-01.pdf","jir_short_summary":"In the second quarter of the fiscal year ending March 2027, all three business segments recorded revenue growth. Revenue was 14,284 million yen, operating income 2,150 million yen, ordinary income 2,185 million yen, and interim net income 1,577 million yen. For the second half, a substantial revenue increase is expected from the particle measurement instruments segment, while hearing aids and medical testing instruments are expected to see continued weak replacement demand. Dividend is expected at approximately 90 yen for the full year (up from 85 yen). Total assets were 43,161 million yen, and the equity ratio was 83.5%.","jir_summary":"### Business Performance Overview\nIn the second quarter of the fiscal year ending March 2027, revenue increased across the particle measurement instruments, medical devices, and environmental equipment segments. The particle measurement instruments segment is expected to see a substantial revenue increase due to firm semiconductor demand and data center expansion. Medical devices and hearing aids are expected to recover market-wise, but replacement demand remains subdued. Environmental equipment benefited from seismometer replacement projects and expansion in overseas markets. Total assets were approximately 43,160.6 million yen, and the equity ratio was 83.5%, indicating a solid financial foundation.\n\n### Outlook and Impact for Investors\nIn the second half, demand expansion for particle measurement instruments is expected, supporting revenue and profit growth. However, the performance of hearing aids and medical testing instruments could swing up or down depending on the timing of replacement demand recovery. The dividend is assumed to be 90 yen for the full year (indicating a potential upward revision from the prior year payout of 85 yen), suggesting continued improvement in shareholder returns.","jir_financial_highlights":"Revenue: 14,284 (Year-over-Year (YoY) interim period +4.9%)\nOperating Income: 2,150 (Year-over-Year (YoY) interim period +8.3%)\nOrdinary Income: 2,185 (Year-over-Year (YoY) interim period +7.6%)\nInterim Net Income: 1,577 (Year-over-Year (YoY) interim period +8.7%)\nInterim Net Income per Share: 127.91 (Not comparable due to lack of prior period per-share data)","jir_category":"","jir_hashtags":"#Rion, #FinancialSummary, #InterimResults","jir_key_figures":"Revenue: 14,284 million yen (Year-over-Year interim period +4.9%)\nOperating Income: 2,150 million yen (Year-over-Year interim period +8.3%)\nOrdinary Income: 2,185 million yen (Year-over-Year interim period approximately +8%)","jir_meta_title":"Rion Co., Ltd. Q2 FY2027 Financial Summary | Revenue 14,284 million yen, Operating Income 2,150 million yen","jir_meta_description":"Summary of Rion Co., Ltd.'s financial results for the second quarter of FY2027. Revenue: 14,284 million yen; Operating Income: 2,150 million yen; Ordinary Income: 2,185 million yen; Interim Net Income: 1,577 million yen. Segment trends, outlook, and dividend policy are discussed.","jir_og_title":"Rion Co., Ltd. | Key Points of Q2 FY2027 Financial Results","jir_og_description":"Rion's interim results show revenue growth across all segments, driven by semiconductor-related demand and overseas expansion. Dividend forecast may be raised to 90 yen. Financial position remains stable.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025-09\\\",\\\"2026-09\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[13621,14284]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2025-09\\\",\\\"2026-09\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[1984,2150]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Particle Measurement Instruments\\\",\\\"Hearing Aids\\\",\\\"Medical Testing Instruments\\\",\\\"Acoustics & Vibration Measurement Instruments\\\"],\\\"datasets\\\":[{\\\"data\\\":[10143,4964,618,0]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Margin Analysis\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Operating Margin\\\"],\\\"datasets\\\":[{\\\"data\\\":[\\\"Unknown\\\"]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Guidance Comparison\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":{}}\"}]","ir_related_company":57169,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-136654","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n